[HTML][HTML] Construction of a two-gene immunogenomic-related prognostic signature in lung squamous cell carcinoma

X Zhang, J Xiao, X Fu, G Qin, M Yu… - Frontiers in Molecular …, 2022 - frontiersin.org
Lung cancer has the highest tumor incidence in China. Lung squamous cell carcinoma
(LUSC) is the most common type, accounting for 40–51% of primary lung cancers. LUSC is …

Long-Term Outcomes of Ablative Carbon-Ion Radiotherapy for Central Non-Small Cell Lung Cancer: A Single-Center, Retrospective Study

S Aoki, H Ishikawa, M Nakajima, N Yamamoto, S Mori… - Cancers, 2024 - mdpi.com
Simple Summary Ablative radiotherapy for central early stage non-small cell lung cancer
(NSCLC) is controversial in its feasibility and optimal dose prescription due to the risk of …

NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model

MA Zakaria, NF Rajab, EW Chua, GT Selvarajah… - Scientific Reports, 2021 - nature.com
Mice have served as an excellent model to understand the etiology of lung cancer for years.
However, data regarding dual-stage carcinogenesis of lung squamous cell carcinoma …

[PDF][PDF] Deep-Shrimp Net fostered lung cancer classification from CT images

V Deepa, PM Fathimal - Int. J. Image Graph. Signal Process., 2023 - researchgate.net
Lung cancer affects the majority of people, due to genetic changes in lung tissues. Several
existing methods on lung cancer detection are utilized with machine learning, but it does not …

Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy

L Mishra, L Kumari, Y Sharma, K Chahar… - Journal of Nanoparticle …, 2024 - Springer
Lung cancer is a complicated thoracic malignancy globally, resulting in molecular,
biomolecular, and signaling pathway abnormalities. It is the most lethal form of cancer …

Determination of the risk of tumor progression in patients with early stages of adenocarcinoma and squamous cell lung carcinoma based on laboratory parameters

AD Tahanovich, NN Kauhanka, VI Prohorova… - … ), Supplement Series B …, 2022 - Springer
Non-small cell lung cancer (NSCLC) dominates in the morbidity of lung cancer. In stage I,
only 60–70% patients overcome the 5-year survival barrier, and in stage II 5-year survival …

Explainable Artificial Intelligence in Medical Imaging: A Case Study on Enhancing Lung Cancer Detection through CT Images

TR Noviandy, A Maulana, T Zulfikar… - … Journal of Case …, 2024 - heca-analitika.com
This study tackles the pressing challenge of lung cancer detection, the foremost cause of
cancer-related mortality worldwide, hindered by late detection and diagnostic limitations …

SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

W Hou, GS Li, L Gao, HP Lu, HF Zhou, JL Kong… - BMC Medical …, 2022 - Springer
Background The roles and clinical values of synaptojanin 2 (SYNJ2) in lung squamous cell
carcinoma (LUSC) remain unclear. Methods A total of 2824 samples from multi-center were …

[HTML][HTML] Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

PH Lee, CJ Chiang, JS Tseng, ZR Zheng… - Frontiers in …, 2023 - frontiersin.org
Background: For patients with T2aN0 stage IB lung adenocarcinoma, benefits of adjuvant
chemotherapy remain controversial. Here, we aimed to evaluate such benefits. Methods …

Automated histopathological detection and classification of lung cancer with an image pre-processing pipeline and spatial attention with deep neural networks

T Nayak, N Gokulkrishnan, K Chadaga… - Cogent …, 2024 - Taylor & Francis
Lung Cancer is a major cancer in the world and specifically India. Histopathological
examination of tumorous tissue biopsy is the gold standard method used to clinically identify …